News · Yonhap News Agency·

Hyundai Pharmaceutical: "Supplementary data for abortion pill approval to be submitted by next month"

Predicted impact: Medium

Supplementary data for abortion pill approval due next month; approval outcome uncertain, company is small (about ₩214B value).

Comments

Sign in to comment

No comments yet. Start the conversation.

Comments are people's own views. Nothing here is financial advice.